Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Hinkley Point C Nuclear Power Station Advances CCNSG Safety Passport Collaboration to Ensure Site Safety During Peak Construction
Hinkley Point C (HPC) nuclear power station in the UK is deepening its collaboration with the Client Contractor National Safety Group (CCNSG) to safeguard thousands of workers on site during the peak construction phase. Located in Somerset, the project is progressively transitioning from civil works to mechanical and electrical installation, placing greater demands on unified safety access standards and workforce competency. The CCNSG Safety Passport scheme, delivered by the Engineering Construction Industry Training Board (ECITB), has been operating in the engineering construction industry for over 30 years, with more than 85,500 active cardholders. The scheme is industry-led and continuously overseen by a relevant committee, of which Hinkley Point C is a member.
2026-08-13
Jellyfish Blockage Forces Shutdown of French Nuclear Units; Experts Say Shutdown Demonstrates Effectiveness of Safety Systems
2026-08-13
Dong Baotong, Director of the National Nuclear Safety Administration: China's nuclear safety level remains among the top internationally, and during the "15th Five-Year Plan" period, the number of operating nuclear power units in China will rank first in the world
2026-08-13
South Korea's Wolsong Nuclear Power Plant Units 2, 3, and 4 Pressure Tube Procurement Pushed for Preliminary Feasibility Study Exemption, Sparking Controversy
2026-08-13
Philippine Energy Regulatory Commission Supports Nuclear Energy Legislation, Emphasizing Regulatory Alignment and Consumer Protection
2026-08-13
Study Reveals Three-Dimensional Pore Networks Inside Uranium-Zirconium Metallic Nuclear Fuel
2026-08-13
UAE Releases 2025 Annual Nuclear Regulatory Report, Highlighting Nuclear Safety and Peaceful Use Achievements
2026-08-13
French nuclear fleet output drops to 59% of full capacity
2026-08-13
Egypt Plans to Expand Dabaa Nuclear Power Plant, Talks on New Reactors Signal Energy Transition
2026-08-13
From July 18 to August 1, the Institute of Modern Physics of the Chinese Academy of Sciences hosted the Frontier Workshop on Nuclear Structure and Reactions. Funded by the Special Fund for Theoretical Physics of the National Natural Science Foundation of China, the workshop attracted 89 young faculty members, postdoctoral researchers, and graduate students from over 30 universities and research institutions nationwide. Twenty-one experts in nuclear physics were invited to give lectures, totaling nearly 80 class hours. Academician of the Chinese Academy of Sciences and President of East China Normal University, Professor Ma Yugang; Academician of the Chinese Academy of Sciences and Professor at Tsinghua University, Zou Bingsong; Director of the Institute of Modern Physics, Professor Sun Zhiyu; as well as representative lecturers Professor Ye Yanlin and Professor Yang Xiaofei from Peking University...
2026-08-13
The application of nuclear technology is not limited to power generation and heating. In areas such as agricultural pest control, animal health, and disease vector management, the Sterile Insect Technique (SIT) based on cobalt-60 gamma rays is playing an important role. The core approach of SIT involves mass-rearing target pests in specialized facilities, separating males, and then irradiating them with a cobalt-60 gamma ray source. The radiation causes DNA breaks in the reproductive cells of male insects, leaving them able to fly and mate with wild females but unable to produce viable offspring. As large numbers of sterile males are continuously released, the proportion of ineffective matings in the wild population increases, pest numbers decline generation after generation, and under certain conditions...
2026-08-13
The integration of nuclear technology with agricultural production is demonstrating increasingly tangible value in Indian farmlands. Through radiation-induced mutation and hybrid breeding techniques, the Bhabha Atomic Research Centre in India has successively developed 72 improved crop varieties, covering peanuts, rice, mung beans, mustard, and other crops. India's Minister of State Jitendra Singh disclosed this progress in a written reply to Parliament, showing that the peaceful application of nuclear science has extended from laboratories to the frontlines of agricultural production. In terms of variety composition, peanut new varieties are the most numerous, reaching 17; rice has 10, mung beans and mustard 9 each, black gram 8, pigeon pea 5, sorghum 3, and cowpea, wheat, and soybean 2 each. Additionally...
2026-08-13
US biotechnology company Valion Bio announced on August 12 that the safety study of its investigational therapeutic candidate Entolimod for radiation-induced gastrointestinal injury is scheduled to commence this week. The study is being advanced by the Armed Forces Radiobiology Research Institute (AFRRI) under a contract with the National Institute of Allergy and Infectious Diseases (NIAID), as part of a government-funded research program. According to the company's disclosure, Entolimod has been delivered to AFRRI, the study has received approval from the Institutional Animal Care and Use Committee (IACUC), and the experimental animals are currently in the pre-dosing acclimation phase. The safety study will confirm the tolerability of Entolimod in the animal strain used by AFRRI...
2026-08-13
ASP Isotopes Inc. recently presented its expansion plans for isotope production, radiopharmaceuticals, and helium operations at Canaccord Genuity's 46th Annual Growth Conference. The company aims to begin commercial delivery of stable isotopes including silicon-28, carbon-14, and ytterbium-176 in the second half of 2026. Victor Petkov, the company's Chief Commercial Officer, stated that ASP Isotopes is leveraging its proprietary enrichment technology to serve electronics, nuclear medicine, and nuclear fuel-related markets. Currently, the company operates three production facilities in Pretoria, South Africa, primarily producing silicon-28 for semiconductor applications, as well as carbon-14 and ytterbium-176 for nuclear medicine-related uses. Regarding isotope supply...
2026-08-13
Anhui Juhe Haizhi Technology Co., Ltd., jointly established by Jianghuai Laboratory, the Institute of Energy at Hefei Comprehensive National Science Center, Keda Silicon Valley, and Anhui Penggong Intelligent Equipment Technology Co., Ltd., has officially settled in Hefei. The company focuses on the industrialization of embodied intelligent equipment for extreme environments, with key deployments in high-risk operational scenarios such as nuclear radiation, deep sea, and specialty chemicals. Juhe Haizhi plans to release two embodied intelligent robots for extreme environments by the end of August 2026. Among them, the commercial fusion radiation-resistant maintenance robot is one of the key products to be released, providing unmanned intelligent maintenance solutions for nuclear radiation-related scenarios, with neutron target maintenance for Boron Neutron Capture Therapy (BNCT) devices being one of its core application scenarios...
2026-08-13
August 12 news, Xi'an Maistop Technology Co., Ltd. recently completed its Pre-A round of financing, with investors including the Central Enterprise Strategic Emerging Fund and Guoxin Venture Capital Fund, both under China Reform Holdings Corporation. The proceeds from this round will primarily be used for site construction, equipment procurement, technology R&D, and daily operations. Founded in 2019, Maistop is a technology enterprise engaged in the R&D and production of medical radionuclides as well as nuclear medicine technical services. The company focuses on the preparation of medical radionuclides via the electron accelerator photonuclear reaction method, with core products including Actinium-225, Lead-212, Copper-67, and Molybdenum-99. Among these, Actinium-225 is a scarce radionuclide of significant interest in alpha-emitting nuclide targeted therapy, with relatively strong global clinical demand...
2026-08-13
